Trial · NCT01790048
Whey Permeate Study
NCT01790048, Not applicable, Completed, Washington University School of Medicine; results first posted 2019-01-17
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Whey Permeate Study. Trials, record NCT01790048. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01790048
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Whey Permeate Study
- NCT number
- NCT01790048
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 2,259 participants, actual
- Lead sponsor
- Washington University School of Medicine
- Conditions
- Malnutrition
- Interventions
- Whey permeate RUSF, Soy Protein RUSF
- First posted
- 2013-02-12
- Last updated
- 2019-01-17
- Results first posted
- 2019-01-17
Source ClinicalTrials.gov
Registered outcomes6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Recovery From Moderate Acute Malnutrition (MAM) | 3 months | The primary outcome measures will be recovery from MAM (achieving MUAC ≥ 12.5 cm by 12 weeks) or failure (death, development of severe acute malnutrition, transfer to hospital for inpatient care, failure to recover from MAM by 12 weeks, default). |
| Secondary | Weight | 3 months | Amount of weight gained over the course of treatment |
| Secondary | Height | 3 months | Amount of height gained over the intervention period. |
| Secondary | Mid-Upper-Arm Circumference (MUAC) Gain | 3 months | Gain in mid-upper arm circumference |
| Secondary | Time to Graduation | 3 months | The amount of time required for a patient to reach recovery |
| Secondary | Adverse Events | 3 months | Any adverse events from the supplementary foods reported in the 3 month time frame. |
Source ClinicalTrials.gov
Outcomes6
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Recovery From Moderate Acute Malnutrition (MAM) | 3 months | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Weight | 3 months | Gain (g/kg/day) | MEAN | |
| SECONDARY | Height | 3 months | mm/d | MEAN | |
| SECONDARY | Mid-Upper-Arm Circumference (MUAC) Gain | 3 months | mm/d | MEAN | |
| SECONDARY | Time to Graduation | 3 months | days | MEAN | |
| SECONDARY | Adverse Events | 3 months | Participants | COUNT_OF_PARTICIPANTS |
Source ClinicalTrials.gov
Results by group12
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Recovery From Moderate Acute Malnutrition (MAM) | Whey Permeate RUSF | 960 | Participants | ||
| Recovery From Moderate Acute Malnutrition (MAM) | Soy Protein RUSF | 874 | Participants | ||
| Weight | Whey Permeate RUSF | 2.95 | Standard Deviation 2.04 | Gain (g/kg/day) | |
| Weight | Soy Protein RUSF | 2.79 | Standard Deviation 2.16 | Gain (g/kg/day) | |
| Height | Whey Permeate RUSF | 0.30 | Standard Deviation 0.28 | mm/d | |
| Height | Soy Protein RUSF | 0.29 | Standard Deviation 0.29 | mm/d | |
| Mid-Upper-Arm Circumference (MUAC) Gain | Whey Permeate RUSF | 0.26 | Standard Deviation 0.27 | mm/d | |
| Mid-Upper-Arm Circumference (MUAC) Gain | Soy Protein RUSF | 0.22 | Standard Deviation 0.28 | mm/d | |
| Time to Graduation | Whey Permeate RUSF | 29.3 | Standard Deviation 19.0 | days | |
| Time to Graduation | Soy Protein RUSF | 30.4 | Standard Deviation 20.1 | days |
1 to 10 of 12Source ClinicalTrials.gov
See all 12 results by groupParticipant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Whey Permeate RUSF | 1,156 | |
| Overall Study | STARTED | Soy Protein RUSF | 1,103 | |
| Overall Study | COMPLETED | Whey Permeate RUSF | 1,144 | |
| Overall Study | COMPLETED | Soy Protein RUSF | 1,086 | |
| Overall Study | NOT COMPLETED | Whey Permeate RUSF | 12 | |
| Overall Study | NOT COMPLETED | Soy Protein RUSF | 17 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Whey Permeate RUSF | ||
| Total, all-cause mortality | Soy Protein RUSF | ||
| Total, other adverse events | Whey Permeate RUSF | 0 | 1,144 |
| Total, other adverse events | Soy Protein RUSF | 0 | 1,086 |
| Total, serious adverse events | Whey Permeate RUSF | 0 | 1,144 |
| Total, serious adverse events | Soy Protein RUSF | 0 | 1,086 |
Source ClinicalTrials.gov
Papers13
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons3
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|---|
| Whey Permeate RUSF vs Soy Protein RUSF: Recovery From Moderate Acute Malnutrition (MAM) | Trial comparisons |
| Whey Permeate RUSF vs Soy Protein RUSF: Adverse Events | Trial comparisons |
| Whey Permeate RUSF vs Soy Protein RUSF: serious adverse events | Trial comparisons |
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT01790048
GET https://conductscience.org/api/trials/v1/NCT01790048/registered